ACC Online Courses offer the cardiovascular community a collection of resources and newly developed, evidence-based educational activities across topics such as lipid management, valvular heart disease, CVD and influenza vaccine, SGLT2i's, and cardiomyopathies.
Stay up to date on the latest science and guidelines, and learn at your own pace through various learning formats including infographics, expert videos, podcasts, and interactive learning modules.
Increase awareness and knowledge on the various types of devices, their strengths and limitations, and appropriate selection of patients who may benefit from cardiac monitoring.
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. Access resources and education to address knowledge gaps in the identification and appropriately managing HCM to reduce the burden of disease progression.
Build greater awareness of the prevalence and diagnosis of cardiac amyloidosis and advancements in imaging technology and treatment, and improve differential diagnosis and expedite referral and treatment.
Understand the importance of assessing risk, monitoring, and managing AFib and other CV risk factors for cancer patients focused on the treatment for chronic lymphocytic leukemia/lymphoma.
Improve knowledge in the assessment of Mitral Regurgitation to determine etiology, mechanism and severity to guide timely and optimal intervention strategies and advance patient care.
Learn best practices and emerging science across practice-changing topics in care including women's health, SGLT2i's, new nonstatins, hypertrophic cardiomyopathy and cardiac amyloidosis.
Learn to address risk assessment in ASCVD, LDL-C lowering therapies, the science behind PCKS9 inhibitors and how to develop a guideline-driven treatment plan that optimizes therapy for ASCVD patients.